Dear Fellow ShareholdersPlease amend, add, delete and ask this...

Dear Fellow Shareholders
Please amend, add, delete and ask this list of questions at all locations:

1. Why are only 10 out of the 100 or so CANVAS trial centres operational. How will the delay affect the trial integrity, timeframe and cashflow.

2. Is CANVAS recruitment slow. Why. How many women have been recruited. When is the full and final recruitment expected.

3. The company has 28 million in the Bank as per latest quarterly. Approx. 5 million is spent each quarter. Cash will be over by 1st quarter next year. Will this money be enough or will there be a cap raising.

4. Any major problems with the study? Is management happy with the progress?

5. When are updates on phase 2b results and ICS data expected. Are results promising. – (this may be announced in the presentation)

6. Any update on trials for other cancers.

7. Any partnering interest for big pharma.

8. Status of oral HPV.

9. Why did MR sell so many shares, if he believes the company is promising.

10. Any comments on the flopped Nasdaq listing.

Cheers,Brainy - I will try and attend in Sydney